Clinical Trial Update: Drug Risk Aversion Calculator Use to Facilitate MS Patient Self-efficacy [NA]

View source ↗

Summary

A Duke University clinical trial evaluating a Drug Risk Aversion Calculator for facilitating multiple sclerosis patient self-efficacy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Duke University | Conditions: Multiple Sclerosis | NA | Status: WITHDRAWN